Search
for
Sort by
Research 361–390 of 1000+
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
- Chronic graft versus host disease and skin
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Omega Fatty Acids in Hair Loss Disorders: A Scoping Review of Preclinical and Clinical Evidence
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- An Updated in the Management of Alopecia Areata
- Alopecia Areata in Twins With Autoimmune Thyroiditis: Personal Observations
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Macrophages in Skin Wounds: Functions and Therapeutic Potential
- Alopecia Areata: An Autoimmune Disease of Multiple Players
- The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier
- Skin ‑ a vast organ with immunological function (Review)
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Bioinformatics analysis of genes associated with the patchy-type alopecia areata: CD2 may be a new therapeutic target
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Malnutrition and Allergies: Tipping the Immune Balance towards Health
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
- The Human Skin Microbiome in Selected Cutaneous Diseases
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- Long-acting microneedle formulations